These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34847741)

  • 1. CRISPR/Cas9-Mediated Gene Editing in Porcine Models for Medical Research.
    Gao M; Zhu X; Yang G; Bao J; Bu H
    DNA Cell Biol; 2021 Dec; 40(12):1462-1475. PubMed ID: 34847741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The advancements, challenges, and future implications of the CRISPR/Cas9 system in swine research.
    Zhang J; Khazalwa EM; Abkallo HM; Zhou Y; Nie X; Ruan J; Zhao C; Wang J; Xu J; Li X; Zhao S; Zuo E; Steinaa L; Xie S
    J Genet Genomics; 2021 May; 48(5):347-360. PubMed ID: 34144928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precision genome editing in plants: state-of-the-art in CRISPR/Cas9-based genome engineering.
    Wada N; Ueta R; Osakabe Y; Osakabe K
    BMC Plant Biol; 2020 May; 20(1):234. PubMed ID: 32450802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
    Ahmad G; Amiji M
    Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Livestock Gene Editing by One-step Embryo Manipulation.
    Navarro-Serna S; Vilarino M; Park I; Gadea J; Ross PJ
    J Equine Vet Sci; 2020 Jun; 89():103025. PubMed ID: 32563448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges.
    Pei WD; Zhang Y; Yin TL; Yu Y
    Brief Funct Genomics; 2020 May; 19(3):215-228. PubMed ID: 31819946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of genome-editing systems to enhance available pig resources for agriculture and biomedicine.
    Lee K; Farrell K; Uh K
    Reprod Fertil Dev; 2019 Jan; 32(2):40-49. PubMed ID: 32188556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the genome editing tool CRISPR/Cas9 in non-human primates.
    Luo X; Li M; Su B
    Dongwuxue Yanjiu; 2016 Jul; 37(4):214-9. PubMed ID: 27469252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
    Zhang Y; Sastre D; Wang F
    Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress and application of genome-edited pigs in biomedical research].
    Huang YQ; Li GL; Yang HQ; Wu ZF
    Yi Chuan; 2018 Aug; 40(8):632-646. PubMed ID: 30117419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR Editing in Biological and Biomedical Investigation.
    Zhang H; McCarty N
    J Cell Biochem; 2017 Dec; 118(12):4152-4162. PubMed ID: 28467679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic gene editing in haematological disorders with CRISPR/Cas9.
    Jensen TI; Axelgaard E; Bak RO
    Br J Haematol; 2019 Jun; 185(5):821-835. PubMed ID: 30864164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creating cell and animal models of human disease by genome editing using CRISPR/Cas9.
    Zarei A; Razban V; Hosseini SE; Tabei SMB
    J Gene Med; 2019 Apr; 21(4):e3082. PubMed ID: 30786106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in therapeutic application of CRISPR-Cas9.
    Sun J; Wang J; Zheng D; Hu X
    Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-Genome Sequencing Reveals Rare Off-Target Mutations in
    Li Z; Lan J; Shi X; Lu T; Hu X; Liu X; Chen Y; He Z
    CRISPR J; 2024 Feb; 7(1):29-40. PubMed ID: 38353621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.